For the information of buyers and dealers: the production of AC-262 was launched. This medication belongs to the SARMs of the 5th generation and has many positive functions: reduces the effect of dihydrotestosterone on the human body and reduces the level of luteinizing hormone.

Our company launched the production of the BPC-157 peptide. This product is already available for shipment to distributors. This peptide includes 15 amino acids and is absolutely safe.

The production of the ACE-031 peptide – a soluble form of the activin receptor of IIB type – was launched. This investigational peptide is a recombinant fusion protein that blocks the action of myostatin and other related proteins that restrict the muscle tissue growth rate.

We officially bring to the notice of consumers and distributors the following information. Currently, a transition to a package with a new design for SARM medications is being carried out. In connection with this, the substitution of products in the package of the previous type takes place.

Selective androgen receptor modulators have a great importance in the modern medicine and a great prospects for development. This drugs allows to selectively effect on specific  receptors in organism without causing adverse effects on other tissues and organs.

Our company has launched the production of peptides in a spray form for intranasal use. This method of drug administration provides high bioavailability and a rapid therapeutic effect. Consumers of our products appreciated popularity of sprays.